Longitudinal and personalized detection of circulating tumor DNA (ctDNA) for monitoring efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma (HCC) - Hsu, C; Lu, S; Abbas, A
J Clin Oncol 2020;38(15):